CEBPZ and acute myeloid leukemia: Combining all of these supporting evidences, our data and analyses confirmed that the reduction level of fusion transcripts and baseline characteristics at initial diagnosis are the most important genetic features in CBF-AML when predicting long-term outcome and they provide complementary prognostic information.